Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.ophtha.2004.06.038
DC Field | Value | |
---|---|---|
dc.title | One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia | |
dc.contributor.author | Tan, D.T.H. | |
dc.contributor.author | Lam, D.S. | |
dc.contributor.author | Chua, W.H. | |
dc.contributor.author | Shu-Ping, D.F. | |
dc.contributor.author | Crockett, R.S. | |
dc.date.accessioned | 2016-11-28T10:15:58Z | |
dc.date.available | 2016-11-28T10:15:58Z | |
dc.date.issued | 2005-01 | |
dc.identifier.citation | Tan, D.T.H., Lam, D.S., Chua, W.H., Shu-Ping, D.F., Crockett, R.S. (2005-01). One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmology 112 (1) : 84-91. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ophtha.2004.06.038 | |
dc.identifier.issn | 01616420 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/131076 | |
dc.description.abstract | To evaluate the safety and efficacy of the relatively selective M 1-antagonist, pirenzepine ophthalmic gel (gel), in slowing the progression of myopia in school-aged children. Parallel-group, placebo-controlled, randomized, double-masked study. Three hundred fifty-three healthy children, 6 to 12 years old, with a spherical equivalent (SE) of -0.75 to -4.00 diopters (D) and astigmatism of ≤1.00 D. Subjects underwent a baseline complete eye examination, and regular examinations over a 1-year period. The study was conducted at 7 academic centers and clinical practices in Asia. Subjects received 2% gel twice daily (gel/gel), 2% gel daily (evening, placebo/gel), or vehicle twice daily (placebo/placebo) in a 2:2:1 ratio, respectively, for 1 year. Spherical equivalent under cycloplegic refraction. At study entry, mean SE refraction was -2.4±0.9 D. At 12 months, there was a mean increase in myopia of 0.47 D, 0.70 D, and 0.84 D in the gel/gel, placebo/gel, and placebo/placebo groups, respectively (P | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ophtha.2004.06.038 | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | OPHTHALMOLOGY | |
dc.description.doi | 10.1016/j.ophtha.2004.06.038 | |
dc.description.sourcetitle | Ophthalmology | |
dc.description.volume | 112 | |
dc.description.issue | 1 | |
dc.description.page | 84-91 | |
dc.description.coden | OPHTD | |
dc.identifier.isiut | 000226242800015 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
SCOPUSTM
Citations
139
checked on May 18, 2022
WEB OF SCIENCETM
Citations
127
checked on May 18, 2022
Page view(s)
126
checked on May 12, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.